Velocity11 and NEXUS Biosystems Partner to Provide Fully Integrated Sample Management Solution for AstraZeneca's Global Compound Collection

    POWAY, CALIF. & MENLO PARK, CALIF., April 11 /CNW/ - NEXUS Biosystems and
Velocity11 announced that AstraZeneca recently selected the combination of
NEXUS Biosystems' Universal LabStore and Velocity11's BioCel Automation System
to serve as their Charnwood site's repository for maintaining, managing, and
processing their plate based compound collection.

    The BioCel - Universal LabStore combination system will become a key
element of AstraZeneca Charnwood's HTS Centre, enabling AstraZeneca to support
its current and future screening demand. The combination of Velocity11 and
NEXUS technologies and products offers customers an unprecedented solution in
terms of sample storage format flexibility, processing speed, sample handling
accuracy, and space efficiency. The AstraZeneca system has unique features
including integration of conventional liquid handling technology with
contact-free acoustic dispensing, as well as proprietary AstraZeneca
innovations in storage labware design.

    "The Universal LabStore offers a unique combination of speed,
flexibility, expandability, and functionality for smaller library sizes that,
when combined with Velocity11's BioCel platform, provides customers with a
complete solution for sample management and processing," said Tommy Bui, VP of
Business Development at NEXUS. "We are extremely pleased AstraZeneca again
selected the BioCel platform for the sample processing portion of the system
based on its speed, throughput, flexibility and our proven track record of
successful deployments at AstraZeneca," said Rob Nail, Founder and CEO at

    "We are excited to work closely with Velocity11 and NEXUS to deploy their
systems for compound storage and management," said Dr. Philip Spencer,
Compound Management Team Leader at AstraZeneca. "Based on the successful
implementation of several BioCel systems at a number of the key AstraZeneca
sites coupled with an extensive evaluation of the solutions currently
available, we found the capabilities of the NEXUS Universal LabStore in
combination with the Velocity11 platform to be uniquely suited to offer both
robust efficiency and adaptability to remain competitive throughout their life
cycles and address our long-term strategic needs."

    Velocity11 and NEXUS have recently established a partnership to combine
both companies' best-in-class platforms to deliver an extraordinarily
effective and seamless solution to its customers. The two companies are in the
process of delivering several systems for compound management, maintenance,
and high-speed sample processing to leading pharmaceutical and biotechnology
research organizations.

    About NEXUS Biosystems, Inc.

    NEXUS Biosystems, a privately held company based in Poway, California,
USA, has since 1996 been a developer and provider of enabling technologies and
automation systems for pharmaceutical, biotech, agrochemical and academic
research institutions worldwide. Current products include the Universal
Store(R) and Universal LabStore(R) family of next generation sample storage
and retrieval systems, the Crystal Farm(R) line of protein crystallization
systems, the IRORI(R) line of chemical synthesis technologies and services,
and in No. America and Asia NEXUS is a distributor of the Covaris(TM) line of
ultrasonic products for sample dissolution, resolubulization, and high density
microplate mixing.

    About Velocity11

    Velocity11 is a privately held company based in Menlo Park, California,
USA and is focused on pioneering automation technology solutions for life
science laboratories. The Company's customers comprise most of the major
pharmaceutical and biotechnology companies as well as leading genome centers
and academic institutions. Combining innovative engineering with high
standards of quality and customer service, Velocity11 designs and manufactures
flexible high-performance automation solutions for processes that are
transforming the industry. Velocity11 is committed to providing its customers
with The Ultimate Automation Experience(SM).

    About AstraZeneca

    AstraZeneca is a major international healthcare business engaged in the
research, development, manufacture and marketing of prescription
pharmaceuticals and the supply of healthcare services. It is one of the
world's leading pharmaceutical companies with healthcare sales of $26.47
billion and leading positions in sales of gastrointestinal, cardiovascular,
neuroscience, respiratory, oncology and infection products. AstraZeneca is
listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good

For further information:

For further information: NEXUS Biosystems Tommy Bui, VP, Business
Development, 858-679-0770 or Velocity11 Michael A. Nemzek,
VP, Marketing, 650-846-6600

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890